BIRC5 and neuroblastoma: YM-155 was shown to be cytotoxic to neuroblastoma cells and their multi-drug-resistant clones (IC50 ranging from 0.49~49.3 nM) and targeted Survivin specifically, as validated by RNAi-mediated Survivin depletion assays [58].